Home›Stocks›RLMD

RLMD — structural market context

Relmada Therapeutics, Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 22. Each line shows the earlier value, the later value and their dates.

Price

Close $3.29 (Oct 22) vs $3.21 (Oct 21): +2.49%.

Volume

4.87× its 20-session average (1.3M) on Oct 22.

Includes pre- and post-market trading.

Short interest

Short interest 13.4M shares (settlement Sep 30) vs 14.5M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Insider filings (Form 4)

None recorded in this window.

RLMD events and their magnitude

Latest SEC filing in the event study

Form 4 · purchase · filed 2026-09-11 · View on sec.gov ↗

…

Open the Event Study →

RLMD short interest & days to cover

SHARES SHORT
13.4M
% OF FLOAT
16.2%
DAYS TO COVER
13.0
CHANGE VS PRIOR
-7.2%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (23d ago)

RLMD fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-08-27 · 57d150$4.55
2026-08-07 · 77d23K$5.37
2026-08-06 · 78d10K$5.44

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

RLMD insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 4 purchases · 0 sales

InsiderTypeSharesValueFiled
TRAVERSA SERGIO · director, officer: Chief Executive OfficerPurchase (P)100K$410K2026-09-11
TRAVERSA SERGIO · director, officer: Chief Executive OfficerPurchase (P)100K$418K2026-09-11
Shenouda Maged · officer: Chief Financial OfficerPurchase (P)120K$505K2026-09-11
Shenouda Maged · officer: Chief Financial OfficerPurchase (P)80K$339K2026-09-11

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

Frequently asked questions

What is RLMD's short interest?
As of the FINRA settlement date 2026-09-30, RLMD had 13.4M shares sold short — 16.2% of its float, with 13.0 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying RLMD?
In the last 12 months of SEC Form 4 filings, RLMD recorded 4 insider purchases and 0 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
Is this page telling me to buy or sell RLMD?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with R

RAL · Ralliant CorporationRCUS · Arcus Biosciences, Inc.RDDT · Reddit, Inc.RDEIY · Redeia Corporacion SARGLD · Royal Gold, Inc.RKLB · Rocket Lab CorporationAll R →

RLMD: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.